Although not yet approved in the UK or elsewhere, its currently in Phase 3 trials and may become available as early as 2027
Autism spectrum disorder(ASD) presents with reduced microbial diversity yet increased biomass in pediatric populations (255, 256), featuring a shift from beneficial microorganisms toward spore-forming, antibiotic-resistant, and/or neurotoxin-producing species (257)
The conditions that have been associated with glutathione deficiency include the following: Neurodegenerative diseases such as Alzheimers, Parkinsons and Huntingtons disease and ALS Pulmonary diseases such as COPD, asthma, and acute respiratory distress syndrome Immune system disorders Cardiovascular diseases such as high blood pressure, elevated cholesterol, and heart attacks Chronic age-related disorders such as cataracts, macular degeneration, hearing impairment, and glaucoma Liver disease Cystic fibrosis Aging processes (Pizzorno, 2014)
The endogenous decline of plasma GHK begins well before visible aging 1